AC Immune SA (NASDAQ:ACIU) gets downgraded to Neutral by UBS Group

Analyst Ratings For AC Immune SA (NASDAQ:ACIU)

Story continues below

Today, AC Immune SA (NASDAQ:ACIU) stock was downgraded by UBS Group from Buy to Neutral.

There are 2 Hold Ratings, 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on AC Immune SA (NASDAQ:ACIU) is Buy with a consensus target price of $16.50 per share, a potential 300.49% upside.

Some recent analyst ratings include

  • 2/1/2019-AC Immune SA (NASDAQ:ACIU) gets downgraded to Neutral by UBS Group
  • 1/24/2019-AC Immune SA (NASDAQ:ACIU) had its Buy rating reiterated by HC Wainwright with a $18.00 price target
  • 11/12/2018-AC Immune SA (NASDAQ:ACIU) has coverage initiated with a Outperform rating and $18.00 price target

    Recent Trading Activity for AC Immune SA (NASDAQ:ACIU)
    Shares of AC Immune SA closed the previous trading session at 4,12 +0,47 12,88 % with 4.15 shares trading hands.

    An ad to help with our costs